Unimarck Healthcare Ltd
Glimepiride (1mg) + Metformin (500mg)
Uniglip M 1mg/500mg Tablet ER is a combination of two medicines used to treat type 2 diabetes mellitus in adults.
Tablet ER
Uniglip M 1mg/500mg Tablet ER belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Uniglip M 1mg/500mg Tablet ER is to be taken with food.
Uniglip M 1mg/500mg Tablet ER is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
You have been prescribed this combination medicine as it can control blood sugar better than metformin alone. You should continue to exercise regularly Eat a healthy diet Take your other diabetes medicines along with Uniglip M 1mg/500mg Tablet ER. Take it with food to lower your chance of having an upset stomach. Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting and stomach pain as Uniglip M 1mg/500mg Tablet ER may cause a rare but serious condition called lactic acidosis which is an excess of lactic acid in the blood.
Store this medicine in the container it came in, tightly closed. Refer to the instructions on the packaging or label for specific storage recommendations. Discard unused medication.
Yes, Uniglip M 1mg/500mg Tablet ER may increase the risk of lactic acidosis. It is a medical emergency associated with elevated blood acid levels. It can be triggered by metformin use and is known as MALA (Metformin-associated lactic acidosis). While rare, it poses risks for individuals with pre-existing kidney problems, elderly patients, or those consuming large amounts of alcohol.
Uniglip M 1mg/500mg Tablet ER is a combination of Glimepiride and Metformin. It's prescribed for the treatment of type 2 diabetes mellitus (DM). This medication improves blood glucose levels when combined with a healthy diet and regular exercise.
Common side effects include hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, and headache. In some cases, there's a chance of serious but rare side effects like lactic acidosis.
Yes. Uniglip M 1mg/500mg Tablet ER can cause Vitamin B12 deficiency over time, as it interferes with vitamin absorption in the stomach. Untreated, this could lead to anemia and nerve problems. Symptoms include tingling sensations, numbness in extremities, weakness, urinary issues, changes in mental status, and difficulty maintaining balance (ataxia). It's recommended to consume outside sources of Vitamin B12 at least once a year.
Yes, Uniglip M 1mg/500mg Tablet ER can cause hypoglycemia (low blood sugar). Symptoms include nausea, headaches, irritability, hunger, sweating, dizziness, rapid heart rate, and feelings of anxiety or shakiness. This is more likely if you miss meals, drink alcohol, over-exercise, or take other antidiabetic drugs simultaneously.
No, it's not safe to combine alcohol and Uniglip M 1mg/500mg Tablet ER. Alcohol consumption can lower blood sugar levels and increase the risk of lactic acidosis.